Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Elranatamab in Mitochondrial Diseases: NCT07382739 Clinical Landscape Report 2026
28 September 2026
NCT07382739 clinical landscape for Mitochondrial Diseases: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Aganirsen in Dermatitis, Atopic: NCT07386743 Clinical Landscape Report 2026
28 September 2026
NCT07386743 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ublituximab in Multiple Sclerosis: NCT07389590 Clinical Landscape Report 2026
28 September 2026
NCT07389590 clinical landscape for Multiple Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
V001-GPRC5D in Solid tumor: NCT07395479 Clinical Landscape Report 2026
28 September 2026
NCT07395479 clinical landscape for Solid tumor: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Venetoclax in Acute Myeloid Leukemia: NCT07392814 Clinical Landscape Report 2026
28 September 2026
NCT07392814 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Venetoclax in Acute Myeloid Leukemia: NCT07392242 Clinical Landscape Report 2026
28 September 2026
NCT07392242 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
QL2109 in Multiple Myeloma: NCT07400744 Clinical Landscape Report 2026
28 September 2026
NCT07400744 clinical landscape for Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Dupilumab Biosimilar (Jiangsu Jinghang) in Dermatitis, Atopic: NCT07411755 Clinical Landscape Report 2026
28 September 2026
NCT07411755 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
IBI-3002 in Dermatitis, Atopic: NCT07399067 Clinical Landscape Report 2026
28 September 2026
NCT07399067 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
LVIVO-TaVec400 in Relapse multiple myeloma: NCT07399444 Clinical Landscape Report 2026
28 September 2026
NCT07399444 clinical landscape for Relapse multiple myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Semaglutide (Novo Nordisk) in Diabetes Mellitus, Type 2: NCT07401992 Clinical Landscape Report 2026
28 September 2026
NCT07401992 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Apremilast in Arthritis, Psoriatic: NCT07398651 Clinical Landscape Report 2026
28 September 2026
NCT07398651 clinical landscape for Arthritis, Psoriatic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.